Skip to content

The Impact of Involving Informal Health Providers for Tuberculosis Control in Sudan

Triage Plus for TB: Improving Community-Based Provision for TB in Africa. The Impact of Involving Informal Health Providers for Tuberculosis Control in Sudan

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01841541
Acronym
Triage-Plus
Enrollment
380
Registered
2013-04-26
Start date
2009-01-31
Completion date
2012-04-30
Last updated
2013-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis

Keywords

Tuberculosis, Informal providers, Informal carers, Barriers to health system

Brief summary

Training and engaging of unpaid informal providers (such as tea-sellers, women's groups, youth clubs, small traders and religious groups) from poorer localities in TB disease recognition, referral and community awareness raising will increase the access of TB patients to formal health facilities and decrease their delay in initiating TB treatment.

Detailed description

Barriers to accessing health services faced by poor and vulnerable populations are numerous in developing countries. These include; geography, income poverty, lack of trust in the quality of public health services, and lack of empowerment of women and adolescent girls (as patients and carers) to mobilize adequate and timely resources to access these services. The project aims to test if TB case detection can be increased by engaging informal health care providers in active case finding. In one urban district of Khartoum, these providers will be trained to work as first point of entry to the health system using a comprehensive package that includes disease recognition, health communication, and patient referral. In a comparator urban district of Khartoum, no attempts will be made to engage informal providers. By comparing data of TB patients and Lab registers between the intervention and comparator districts in Khartoum, this project aims to test if, and to what extent, these expected effects can be realized. Overall this is a trial of a health policy so individual patients will not be recruited or randomized to one intervention or the other. Rather the policy is being applied in one district while the other district is being used as a comparator.

Interventions

BEHAVIORALReferral of presumptive of TB cases by informal providers

Training of informal providers to effectively refer TB suspects in the community to the primary health care system

Sponsors

The Epidemiological Laboratory (EpiLab), Khartoum-Sudan.
CollaboratorUNKNOWN
The Norwegian Heart and Lung Patients Association (LHL)
CollaboratorUNKNOWN
Liverpool School of Tropical Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
14 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Access point for health seeking by the poor and vulnerable * Active and well known in community * Intervention activities can be confined to intervention area * Based in community/locality * Longevity; long standing * Present in control and intervention areas * Able and willing to complete the training to be Triage-Plus providers (ie giving formal consent)

Exclusion criteria

* Formal health providers, e.g. clinics, labs, hospitals (MOH, NGO or private) * Internationally funded organizations, e.g. international NGOs * Civil servants e.g. teachers

Design outcomes

Primary

MeasureTime frameDescription
Total number of TB patients registered and start receiving treatment in formal health care facilities12 monthsThis will be measured by comparing Data from routine patients registered in formal TB management units in the intervention arm and compare it with the same routine data from the control arm. similar data for the previous year will undergo the same comparison as time control for both arms

Countries

Sudan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026